论文信息 - Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis - 字舞流文

Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis

J. Riancho | F. Gil-Bea | M. J. Sedano | J. Poza | Mónica Zufiría | David Castanedo-Vázquez | A. L. D. Munain | Gorka Fernández Garcia de Eulate

[1] R. Rojas-García,et al. ALS: A bucket of genes, environment, metabolism and unknown ingredients , 2016, Progress in Neurobiology.

[2] G. Landreth,et al. Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis , 2016, Journal of the Neurological Sciences.

[3] J. Hodges,et al. FTD and ALS—translating mouse studies into clinical trials , 2015, Nature Reviews Neurology.

[4] P. Rossini,et al. Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations , 2015, Neurobiology of Aging.

[5] E. White,et al. Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6] J. Berciano,et al. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis. , 2019, Neurologia.